scholarly journals Macrophage activation syndrome after leflunomide treatment in an adult rheumatoid arthritis patient

Rheumatology ◽  
2010 ◽  
Vol 49 (10) ◽  
pp. 2001-2001 ◽  
Author(s):  
M. Ricci ◽  
P. Rossi ◽  
G. De Marco ◽  
V. Varisco ◽  
A. Marchesoni
2015 ◽  
Vol 82 (4) ◽  
pp. 278-279 ◽  
Author(s):  
Marie Leroy ◽  
Guillaume Coiffier ◽  
Charlotte Pronier ◽  
Louise Triquet ◽  
Aleth Perdriger ◽  
...  

2015 ◽  
Vol 2015 ◽  
pp. 1-4 ◽  
Author(s):  
Guido Granata ◽  
Dario Didona ◽  
Giuseppina Stifano ◽  
Aldo Feola ◽  
Massimo Granata

Macrophage activation syndrome (MAS) is a potentially fatal condition. It belongs to the hemophagocytic lymphohistiocytosis group of diseases. In adults, MAS is rarely associated with systemic lupus erythematosus, but it also arises as complication of several systemic autoimmune disorders, like ankylosing spondylitis, rheumatoid arthritis, and adult-onset Still’s disease. Several treatment options for MAS have been reported in the literature, including a therapeutic regimen of etoposide, dexamethasone, and cyclosporine. Here we report a case of 42-year-old woman in whom MAS occurred as onset of systemic lupus erythematosus.


2003 ◽  
Vol 9 (4) ◽  
pp. 253-258 ◽  
Author(s):  
Antonio G. Tristano ◽  
Lady Casanova-Escalona ◽  
Alcira Torres ◽  
Mart??n A. Rodr??guez

Sign in / Sign up

Export Citation Format

Share Document